Embelin binds to human neuroserpin and impairs its polymerisation

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Saga, Giorgia ^a   Sessa, Fabio ^a   Barbiroli, Alberto ^a   Santambrogio, Carlo ^b   Russo, Rosaria ^a   Sala, Michela ^b   Raccosta, Samuele ^c   Martorana, Vincenzo ^c   Caccia, Sonia ^a   Noto, Rosina ^d   Moriconi, Claudia ^d   Miranda, Elena ^d   Grandori, Rita ^b   Manno, Mauro ^c   Bolognesi, Martino ^a   Ricagno, Stefano ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c CNR   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOQUINONE DERIVATIVE; EMBELIN; LIGAND; NEUROPEPTIDE; NEUROSERPIN; PROTEIN BINDING; SERINE PROTEINASE INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ANTAGONISTS AND INHIBITORS; CHEMISTRY; CIRCULAR DICHROISM; HUMAN; KINETICS; MASS SPECTROMETRY; METABOLISM; PROCEDURES; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN STABILITY;

BENZOQUINONES; CIRCULAR DICHROISM; HUMANS; KINETICS; LIGANDS; MASS SPECTROMETRY; NEUROPEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; SERPINS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84953251294     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep18769     Document Type: Article

References (41)

1. Caccia, S., Ricagno, S. & Bolognesi, M. Molecular bases of neuroserpin function and pathology. BioMolecular Concepts 1, 117-130 (2010).
2. Gooptu, B. & Lomas, D. A. Conformational pathology of the serpins: themes, variations, and therapeutic strategies. Annual review of biochemistry 78, 147-176 (2009).
3. Huntington, J. A., Read, R. J. & Carrell, R. W. Structure of a serpin-protease complex shows inhibition by deformation. Nature 407, 923-926 (2000).
4. Kaslik, G. et al. Effects of serpin binding on the target proteinase: global stabilization, localized increased structural flexibility, and conserved hydrogen bonding at the active site. Biochemistry 36, 5455-5464 (1997).
5. Lomas, D. A. & Carrell, R. W. Serpinopathies and the conformational dementias. Nature reviews. Genetics 3, 759-768, doi: 10.1038/nrg907 (2002).
6. Lomas, D. A., Evans, D. L., Finch, J. T. & Carrell, R. W. The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 357, 605-607 (1992).
7. Onda, M., Belorgey, D., Sharp, L. K. & Lomas, D. A. Latent S49P neuroserpin forms polymers in the dementia familial encephalopathy with neuroserpin inclusion bodies. The Journal of biological chemistry 280, 13735-13741 (2005).
8. Tan, L. et al. Characterising the association of latency with alpha(1)-antitrypsin polymerisation using a novel monoclonal antibody. The international journal of biochemistry & cell biology 58, 81-91, doi: 10.1016/j.biocel.2014.11.005 (2015).
9. Whisstock, J. C. & Bottomley, S. P. Molecular gymnastics: serpin structure, folding and misfolding. Current opinion in structural biology 16, 761-768 (2006).
10. Dupont, D. M. et al. Biochemical properties of plasminogen activator inhibitor-1. Frontiers in bioscience 14, 1337-1361 (2009).
11. Yamasaki, M., Li, W., Johnson, D. J. & Huntington, J. A. Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization. Nature 455, 1255-1258 (2008).
12. Yamasaki, M., Sendall, T. J., Pearce, M. C., Whisstock, J. C. & Huntington, J. A. Molecular basis of alpha1-antitrypsin deficiency revealed by the structure of a domain-swapped trimer. EMBO reports 12, 1011-1017, doi: 10.1038/embor.2011.171 (2011).
13. Noto, R. et al. Functional and dysfunctional conformers of human neuroserpin characterized by optical spectroscopies and Molecular Dynamics. Biochimica et biophysica acta 1854, 110-117, doi: 10.1016/j.bbapap.2014.10.002 (2015).
14. Galliciotti, G. & Sonderegger, P. Neuroserpin. Front Biosci 11, 33-45 (2006).
15. Miranda, E. & Lomas, D. A. Neuroserpin: a serpin to think about. Cell Mol Life Sci 63, 709-722 (2006).
16. Davis, R. L. et al. Familial encephalopathy with neuroserpin inclusion bodies. Am J Pathol 155, 1901-1913, doi: 10.1016/S0002-9440(10)65510-1 (1999).
17. Belorgey, D., Crowther, D. C., Mahadeva, R. & Lomas, D. A. Mutant Neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro. The Journal of biological chemistry 277, 17367-17373 (2002).
18. Belorgey, D. et al. Neuroserpin Portland (Ser52Arg) is trapped as an inactive intermediate that rapidly forms polymers: implications for the epilepsy seen in the dementia FENIB. European journal of biochemistry/FEBS 271, 3360-3367 (2004).
19. Miranda, E. et al. The intracellular accumulation of polymeric neuroserpin explains the severity of the dementia FENIB. Human molecular genetics 17, 1527-1539 (2008).
20. Miranda, E., Romisch, K. & Lomas, D. A. Mutants of neuroserpin that cause dementia accumulate as polymers within the endoplasmic reticulum. The Journal of biological chemistry 279, 28283-28291 (2004).
21. Valiente, M. et al. Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell 156, 1002-1016, doi: 10.1016/j.cell.2014.01.040 (2014).
22. Ricagno, S., Caccia, S., Sorrentino, G., Antonini, G. & Bolognesi, M. Human neuroserpin: structure and time-dependent inhibition. Journal of molecular biology 388, 109-121 (2009).
23. Ricagno, S. et al. Two latent and two hyperstable polymeric forms of human neuroserpin. Biophysical journal 99, 3402-3411 (2010).
24. Santangelo, M. G. et al. On the molecular structure of human neuroserpin polymers. Proteins 80, 8-13, doi: 10.1002/prot.23197 (2012).
25. Noto, R. et al. The tempered polymerization of human neuroserpin. PloS one 7, e32444, doi: 10.1371/journal.pone.0032444 (2012).
26. Parfrey, H. et al. Targeting a surface cavity of alpha 1-antitrypsin to prevent conformational disease. The Journal of biological chemistry 278, 33060-33066 (2003).
27. Mallya, M. et al. Small molecules block the polymerization of Z alpha1-antitrypsin and increase the clearance of intracellular aggregates. Journal of medicinal chemistry 50, 5357-5363 (2007).
28. Lin, Z. et al. Structural insight into inactivation of plasminogen activator inhibitor-1 by a small-molecule antagonist. Chemistry &biology 20, 253-261, doi: 10.1016/j.chembiol.2013.01.002 (2013).
29. Heck, A. J. Native mass spectrometry: a bridge between interactomics and structural biology. Nature methods 5, 927-933, doi: 10.1038/nmeth.1265 (2008).
30. Jinyu, L. et al. Conformational effects in protein electrospray-ionization mass spectrometry. Mass Spectrometry Reviews In press (2015).
31. Testa, L., Brocca, S. & Grandori, R. Charge-surface correlation in electrospray ionization of folded and unfolded proteins. Analytical chemistry 83, 6459-6463, doi: 10.1021/ac201740z (2011).
32. Davis, R. L. et al. Familial dementia caused by polymerization of mutant neuroserpin. Nature 401, 376-379 (1999).
33. Davis, R. L. et al. Association between conformational mutations in neuroserpin and onset and severity of dementia. Lancet 359, 2242-2247 (2002).
34. Madani, R. et al. Impaired explorative behavior and neophobia in genetically modified mice lacking or overexpressing the extracellular serine protease inhibitor neuroserpin. Molecular and cellular neurosciences 23, 473-494, doi: S1044743103000770 [pii] (2003).
35. Coutelier, M. et al. Neuroserpin mutation causes electrical status epilepticus of slow-wave sleep. Neurology 71, 64-66 (2008).
36. Hagen, M. C. et al. Encephalopathy with neuroserpin inclusion bodies presenting as progressive myoclonus epilepsy and associated with a novel mutation in the Proteinase Inhibitor 12 gene. Brain pathology 21, 575-582, doi: 10.1111/j.1750-3639.2011.00481.x (2011).
37. Gavrilovic, I. T. & Posner, J. B. Brain metastases: epidemiology and pathophysiology. Journal of neuro-oncology 75, 5-14, doi: 10.1007/s11060-004-8093-6 (2005).
38. Huang, M. et al. Embelin suppresses growth of human pancreatic cancer xenografts, and pancreatic cancer cells isolated from KrasG12D mice by inhibiting Akt and Sonic hedgehog pathways. PloS one 9, e92161, doi: 10.1371/journal.pone.0092161 (2014).
39. Nikolovska-Coleska, Z. et al. Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structurebased computational screening of a traditional herbal medicine three-dimensional structure database. Journal of medicinal chemistry 47, 2430-2440, doi: 10.1021/jm030420 + (2004).
40. Wehrkamp, C. J., Gutwein, A. R., Natarajan, S. K., Phillippi, M. A. & Mott, J. L. XIAP antagonist embelin inhibited proliferation of cholangiocarcinoma cells. PloS one 9, e90238, doi: 10.1371/journal.pone.0090238 (2014).
41. Lomas, D. A., Elliott, P. R., Chang, W. S., Wardell, M. R. & Carrell, R. W. Preparation and characterization of latent alpha 1-antitrypsin. The Journal of biological chemistry 270, 5282-5288 (1995).